Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pietro Andrei"'
Autor:
Elisa Mariella, Gaia Grasso, Martina Miotto, Kristi Buzo, Nicole Megan Reilly, Pietro Andrei, Pietro Paolo Vitiello, Giovanni Crisafulli, Sabrina Arena, Giuseppe Rospo, Giorgio Corti, Annalisa Lorenzato, Carlotta Cancelliere, Ludovic Barault, Giulia Gionfriddo, Michael Linnebacher, Mariangela Russo, Federica Di Nicolantonio, Alberto Bardelli
Publikováno v:
Molecular Oncology, Vol 18, Iss 6, Pp 1460-1485 (2024)
Multiple strategies are continuously being explored to expand the drug target repertoire in solid tumors. We devised a novel computational workflow for transcriptome‐wide gene expression outlier analysis that allows the systematic identification of
Externí odkaz:
https://doaj.org/article/92bbd1f7992a4959a8ac49d3bf307ec5
Autor:
Sabrina Arena, Alberto Bardelli, Federica Di Nicolantonio, Serena Nik-Zainal, Andrea Sartore-Bianchi, Salvatore Siena, Silvia Marsoni, Michael Linnebacher, Pietro Andrei, Gianluca Mauri, Carlotta Cancelliere, Andrea Degasperi, Giorgio Corti, Simona Lamba, Federica Pisati, Gaia Grasso, João M. L. Dias, Annalisa Lorenzato, Rosaria Chilà, Elisa Mariella, Kristi Buzo, Nicole M. Reilly, Erika Durinikova
Supplementary Figure from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::180032a9dec4f433f6ff89c4d0c666ad
https://doi.org/10.1158/1078-0432.22488176.v1
https://doi.org/10.1158/1078-0432.22488176.v1
Autor:
Sabrina Arena, Alberto Bardelli, Federica Di Nicolantonio, Serena Nik-Zainal, Andrea Sartore-Bianchi, Salvatore Siena, Silvia Marsoni, Michael Linnebacher, Pietro Andrei, Gianluca Mauri, Carlotta Cancelliere, Andrea Degasperi, Giorgio Corti, Simona Lamba, Federica Pisati, Gaia Grasso, João M. L. Dias, Annalisa Lorenzato, Rosaria Chilà, Elisa Mariella, Kristi Buzo, Nicole M. Reilly, Erika Durinikova
Supplementary Table from Targeting the DNA Damage Response Pathways and Replication Stress in Colorectal Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eacb7fca88384accbfb34b13a61c8d6
https://doi.org/10.1158/1078-0432.22488170
https://doi.org/10.1158/1078-0432.22488170
Autor:
Sabrina Arena, Alberto Bardelli, Federica Di Nicolantonio, Serena Nik-Zainal, Andrea Sartore-Bianchi, Salvatore Siena, Silvia Marsoni, Michael Linnebacher, Pietro Andrei, Gianluca Mauri, Carlotta Cancelliere, Andrea Degasperi, Giorgio Corti, Simona Lamba, Federica Pisati, Gaia Grasso, João M. L. Dias, Annalisa Lorenzato, Rosaria Chilà, Elisa Mariella, Kristi Buzo, Nicole M. Reilly, Erika Durinikova
Purpose:Genomic instability is a hallmark of cancer and targeting DNA damage response (DDR) is emerging as a promising therapeutic strategy in different solid tumors. The effectiveness of targeting DDR in colorectal cancer has not been extensively ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6003be7c1265b762d7f0da11f2e3ab9b
https://doi.org/10.1158/1078-0432.c.6532661.v1
https://doi.org/10.1158/1078-0432.c.6532661.v1
Autor:
Gaia Grasso, Elisa Marriella, Martina Miotto, Kristi Buzo, Nicole M. Reilly, Pietro Andrei, Pietro P. Vitiello, Giovanni Crisafulli, Sabrina Arena, Giuseppe Rospo, Giorgio Corti, Annalisa Lorenzato, Carlotta Cancelliere, Ludovic Barault, Giulia Gionfriddo, Michael Linnebacher, Mariangela Russo, Federica Di Nicolantonio, Alberto Bardelli
Publikováno v:
Cancer Research. 83:LB058-LB058
The number of effective therapies approved for metastatic colorectal cancer (mCRC) is still limited and multiple strategies are continuously explored to expand the drug target repertoire. Among these, the identification of overexpressed genes has pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::947798c7aac4656ee838ba3e98fd36f7
https://doi.org/10.1158/1538-7445.am2023-lb058
https://doi.org/10.1158/1538-7445.am2023-lb058
Autor:
Anna Montanaro, Anna D'Antuono, Lucas Moron Dalla Tor, Pietro Andrei, Alessia Ciringione, Elisa Cerretani, Federica Vento, Luca Pagliaro, Andrea Gherli, Bruno Lorusso, Elisa Simoncini, Raffaella Zamponi, Costanza Salvatori, Giannalisa Todaro, Roberta La Starza, Cristina Mecucci, Gabriella Sammarelli, Matteo Marchesini, Giovanni Roti
Publikováno v:
Blood. 140:3130-3131
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc0aff6a25e8b6a58ce77207d311d3ac
https://doi.org/10.1182/blood-2022-163069
https://doi.org/10.1182/blood-2022-163069
Autor:
Erika Durinikova, Nicole M. Reilly, Kristi Buzo, Elisa Mariella, Rosaria Chilà, Annalisa Lorenzato, João M. L. Dias, Gaia Grasso, Federica Pisati, Simona Lamba, Giorgio Corti, Andrea Degasperi, Carlotta Cancelliere, Gianluca Mauri, Pietro Andrei, Michael Linnebacher, Silvia Marsoni, Salvatore Siena, Andrea Sartore-Bianchi, Serena Nik-Zainal, Federica Di Nicolantonio, Alberto Bardelli, Sabrina Arena
Publikováno v:
Clinical Cancer Research
Purpose: Genomic instability is a hallmark of cancer and targeting DNA damage response (DDR) is emerging as a promising therapeutic strategy in different solid tumors. The effectiveness of targeting DDR in colorectal cancer has not been extensively e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f4a4edbc830946b7de43e7c14546f28
Autor:
Pietro Paolo Vitiello, Elisa Mariella, Pietro Andrei, Vito Amodio, Giovanni Germano, Annalisa Lorenzato, Carlotta Cancelliere, Alberto Bardelli
Publikováno v:
Cancer Research. 82:4034-4034
Colorectal cancer (CRC) is the third most frequent malignancy and the second leading cause of cancer death worldwide. Despite the increase in therapeutic options for the treatment of metastatic CRC (mCRC), cytotoxic chemotherapy using fluoropyrimidin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3429a11f7a6aea20a2a326cc1e27961
https://doi.org/10.1158/1538-7445.am2022-4034
https://doi.org/10.1158/1538-7445.am2022-4034
Publikováno v:
Seminars in cancer biology. 84
Colorectal cancer (CRC) is one of the most common human malignancies accounting for approximately 10 % of worldwide cancer incidence and mortality. While early-stage CRC is mainly a preventable and curable disease, metastatic colorectal cancer (mCRC)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b61314fbec723111e6d61b437c4bf61
https://pubmed.ncbi.nlm.nih.gov/33848627
https://pubmed.ncbi.nlm.nih.gov/33848627